Navigation Links
America's Pharmaceutical Research Companies Respond to Hurricane Ike's Imminent Landfall
Date:9/12/2008

WASHINGTON, Sept. 12 /PRNewswire-USNewswire/ -- Responding to conditions created by Hurricane Ike in Texas and other Gulf Coast states, the Pharmaceutical Research and Manufacturers of America (PhRMA) has moved from "alert" to "engaged" status - the highest level of activation - as part of its effort to ensure needed medicines are available in areas affected by the storm. PhRMA is working closely with other members of the RxResponse network, http://www.rxresponse.org, to provide assistance to state, local and federal emergency managers to keep the pharmaceutical supply chain open throughout areas hit by Ike.

PhRMA, along with other RxResponse Coordinating Body members, are now convening regular conference calls to manage RxResponse's efforts to coordinate requests for needed medicines and supplies, as well as other critical information about the state of the pharmaceutical supply system throughout the affected region. PhRMA is specifically coordinating with its member companies and asking them to advise the RxResponse team of Ike-related impacts on company operations, as well as to monitor and report all requests for assistance.

"We will do all we can to assist emergency managers in Texas and everyone affected by Hurricane Ike," said PhRMA President & CEO Billy Tauzin. "We are working together with key players in the pharmaceutical supply system and with emergency managers on the ground to help ensure that medicines get to the patients, hospitals and emergency evacuation centers where they are needed most."

Created following Hurricane Katrina, RxResponse is a unique business-sector effort creating a single point of contact for emergency managers and public health leaders seeking help obtaining needed medicines after a natural or man-made disaster. The RxResponse is comprised of: the American Hospital Association, the American Red Cross, the Biotechnology Industry Organization, the Generic Pharmaceutical Association, the Healthcare Distribution Management Association, the National Community Pharmacists' Association and PhRMA.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $44.5 billion in 2007 in discovering and developing new medicines. Industry-wide research and investment reached a record $58.8 billion in 2007.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ExamForce Hires Former (ISC)2 Americas Leader to Head Corporate and Government Sales Efforts
2. Mentice, Inc. Expands Its North American Sales and Clinical Presence With the Hiring of Jeff Sirek as Director of Educational Sales-East and Sue Landsman as Clinical Applications Manager for the Americas.
3. DNA Find in Oregon Is Oldest Yet Discovered in Americas
4. Olympus Corporation of the Americas Names Mark Gumz President & CEO
5. Mentice, Inc. Announces Appointment of Vice-President, Sales and Marketing, Americas
6. Cochlear Americas Announces 2008 Graeme Clark Scholarship Winners
7. Genesis Pharmaceuticals Received New Purchase Orders Worth $12 Million
8. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Laonian Kechuan Tablets
9. DSM Pharmaceutical Products Announces the Appointment of Thats Nice LLC as Agency of Record for Marketing
10. Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary
11. WellSpring Pharmaceutical Corp. Acquires Consumer Product Brands from McNeil Consumer Healthcare -- Deal Enhances US and Canadian Pharmaceutical Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... , ... May 26, 2017 , ... Dr. Alex Rabinovich, ... to announce a new, informational blog post on insurance options. If a Bay Area ... plans may help save time and money. Visiting an in-network provider for a second ...
(Date:5/26/2017)... , ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: the ... Journey to the Cross” is the creation of published authors, Bob and Margaret Massey. ... to say, he is "panther quick and leather tough." His love for others is ...
(Date:5/26/2017)... ... May 26, 2017 , ... “Just What Happened in the Garden of Eden”: retells the ... of Eden” is the creation of published author, Penelope Colt, mother, trader, horse farmer, artist ... to NYC when she was three. At six, they moved to Dayton, Ohio, where ...
(Date:5/26/2017)... ... May 26, 2017 , ... Water damage to the flooring of several classrooms ... left education officials with a number of critical issues to address before students could ... be accomplished with little or no disruption to class schedules. Second, the project had ...
(Date:5/24/2017)... Ca (PRWEB) , ... May 24, 2017 , ... ... effects and background. Understanind and choosing the most appropriate instruments for research and ... critical in research finding. This webinar will focus on innovations in stereo microscopy ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... 2017  Amy Baxter MD, chief executive officer and ... pain relief, was awarded a 2017 Top 40 Healthcare ... recognized at the MM&M Top 40 Healthcare Transformers dinner ... on May 10, 2017. The dinner followed a ... "beyond the pill."  "Innovation goes beyond invention," ...
(Date:5/10/2017)... Hologic, Inc. (Nasdaq: HOLX ) ... second quarter ended April 1, 2017 .   GAAP ... compared to the prior year period as the sale ... gain, while non-GAAP diluted EPS of $0.50 increased 6.4%.  ... constant currency terms.  Excluding the effects of blood screening ...
(Date:5/10/2017)... Md. , May 10, 2017 CSSi, ... solutions for the clinical research industry, is proud to ... www.CSSiEnroll.com . The new website features both enriched content ... user experience and enhances the company,s already well-established position ... industry. "After many months of hard ...
Breaking Medicine Technology: